Editors:
- Includes supplementary material: sn.pub/extras
Part of the book series: Cancer Drug Discovery and Development (CDD&D)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (43 chapters)
-
Nuclear Receptor Superfamily
-
Natural Vitamin D and Synthetic Analogs
-
Retinoids
-
Dehydroepiandrosterone and Structural Analogs
-
-
Signal Transduction Modulators
-
Front Matter
-
About this book
Up-to-date and highly practical, Cancer Chemoprevention, Volumes 1 & 2, offer oncologists, pharmacologists, medicinal chemists, and toxicologists a comprehensive reference survey on the identification of promising cancer chemopreventive agents that will help stimulate further research and the development of novel approvable drugs.
Reviews
"...a valuable addition to any library in a lboratory researching/developing oncology products..." - BTS Newsletter
"...provides a comprehensive reference survey for basic researchers, pharmacologists and clinical oncologists...a must for everyone involved in chemoprevention research." - Annals of Oncology
Editors and Affiliations
-
National Institutes of Health, Rockville, USA
Gary J. Kelloff, Ernest T. Hawk
-
CCS Associates, Mountain View, USA
Caroline C. Sigman
Bibliographic Information
Book Title: Cancer Chemoprevention
Book Subtitle: Volume 1: Promising Cancer Chemopreventive Agents
Editors: Gary J. Kelloff, Ernest T. Hawk, Caroline C. Sigman
Series Title: Cancer Drug Discovery and Development
DOI: https://doi.org/10.1007/978-1-59259-767-3
Publisher: Humana Totowa, NJ
-
eBook Packages: Springer Book Archive
Copyright Information: Springer Science+Business Media New York 2004
Hardcover ISBN: 978-1-58829-076-2
Softcover ISBN: 978-1-61737-342-8
eBook ISBN: 978-1-59259-767-3
Series ISSN: 2196-9906
Series E-ISSN: 2196-9914
Edition Number: 1
Number of Pages: XVI, 697
Number of Illustrations: 58 b/w illustrations, 1 illustrations in colour
Topics: Oncology
Industry Sectors: Biotechnology, Health & Hospitals, Pharma